Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDLXNYSE:EBNASDAQ:EVERNASDAQ:HCAT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDLXCardlytics$1.88+24.5%$1.74$1.22▼$9.48$98.70M1.25983,573 shs3.68 million shsEBEventbrite$2.47+2.3%$2.28$1.81▼$5.92$233.26M2.061.38 million shs621,694 shsEVEREverQuote$24.34-1.3%$23.48$16.63▼$30.03$869.52M0.33548,451 shs607,361 shsHCATHealth Catalyst$3.88+2.1%$3.94$3.49▼$9.24$270.05M1.53605,743 shs405,620 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDLXCardlytics0.00%-15.64%-26.70%-36.55%-82.06%EBEventbrite0.00%-4.91%+3.42%+5.91%-49.90%EVEREverQuote0.00%-2.80%+1.61%-12.09%+28.57%HCATHealth Catalyst0.00%-7.32%-6.40%-14.61%-41.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDLXCardlytics3.6696 of 5 stars3.11.00.02.83.32.50.6EBEventbrite3.8913 of 5 stars3.11.00.03.82.63.30.6EVEREverQuote4.2442 of 5 stars3.64.01.70.02.94.21.3HCATHealth Catalyst4.6339 of 5 stars4.42.00.03.82.92.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDLXCardlytics 2.14Hold$3.5086.17% UpsideEBEventbrite 2.20Hold$4.8396.08% UpsideEVEREverQuote 3.17Buy$32.5033.53% UpsideHCATHealth Catalyst 2.70Moderate Buy$8.00106.19% UpsideCurrent Analyst Ratings BreakdownLatest HCAT, EB, EVER, and CDLX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025CDLXCardlyticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$3.00 ➝ $2.505/8/2025HCATHealth CatalystCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $9.005/8/2025HCATHealth CatalystStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$5.00 ➝ $5.505/6/2025EVEREverQuoteJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $30.005/6/2025EVEREverQuoteNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$38.00 ➝ $38.004/25/2025HCATHealth CatalystCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $6.504/16/2025HCATHealth CatalystKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$7.00 ➝ $5.004/14/2025EBEventbriteBWS FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.00 ➝ $7.004/9/2025HCATHealth CatalystEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Inline4/9/2025HCATHealth CatalystEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ In-Line$6.00 ➝ $4.00(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDLXCardlytics$272.59M0.36$0.80 per share2.36$3.43 per share0.55EBEventbrite$312.65M0.75N/AN/A$1.89 per share1.30EVEREverQuote$575.76M1.51N/AN/A$2.37 per share10.27HCATHealth Catalyst$311.27M0.87N/AN/A$6.38 per share0.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDLXCardlytics-$134.70M-$3.56N/AN/AN/A-93.55%-110.67%-32.70%7/28/2025 (Estimated)EBEventbrite-$26.48M-$0.19N/AN/AN/A-2.42%-4.44%-0.91%8/6/2025 (Estimated)EVEREverQuote-$51.29M$1.0271.5930.05N/A3.31%13.94%9.24%8/4/2025 (Estimated)HCATHealth Catalyst-$118.15M-$1.15N/AN/AN/A-26.20%-7.51%-3.72%8/6/2025 (Estimated)Latest HCAT, EB, EVER, and CDLX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025EBEventbrite-$0.08-$0.07+$0.01-$0.07$72.88 million$73.83 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDLXCardlyticsN/AN/AN/AN/AN/AEBEventbriteN/AN/AN/AN/AN/AEVEREverQuote$0.240.99%N/A23.53%N/AHCATHealth CatalystN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDLXCardlytics2.401.181.18EBEventbrite1.341.561.56EVEREverQuoteN/A2.332.33HCATHealth Catalyst0.321.411.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDLXCardlytics68.10%EBEventbrite91.64%EVEREverQuote91.54%HCATHealth Catalyst85.00%Insider OwnershipCompanyInsider OwnershipCDLXCardlytics4.40%EBEventbrite21.46%EVEREverQuote29.79%HCATHealth Catalyst2.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDLXCardlytics50052.50 million48.59 millionOptionableEBEventbrite88094.63 million76.09 millionOptionableEVEREverQuote61035.72 million24.82 millionOptionableHCATHealth Catalyst1,20069.60 million59.33 millionOptionableHCAT, EB, EVER, and CDLX HeadlinesRecent News About These CompaniesHealth Catalyst, Inc. (NASDAQ:HCAT) Receives $8.00 Average Target Price from AnalystsJune 16 at 2:37 AM | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by BrokeragesJune 13 at 2:40 AM | marketbeat.comHCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding UncertaintyJune 12, 2025 | msn.comHealth Catalyst: Ignite Platform Is A Growth CatalystJune 10, 2025 | seekingalpha.comNepsis Inc. Grows Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)June 10, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 6,057 SharesJune 10, 2025 | insidertrades.comTwo Sigma Investments LP Makes New $496,000 Investment in Health Catalyst, Inc. (NASDAQ:HCAT)June 10, 2025 | marketbeat.comBenjamin Landry Sells 6,057 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) StockJune 9, 2025 | marketbeat.comAmeriprise Financial Inc. Has $478,000 Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)June 5, 2025 | marketbeat.comJane Street Group LLC Sells 102,244 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)June 2, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 79,341 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)May 30, 2025 | marketbeat.comPalogic Value Management L.P. Acquires New Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)May 29, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New Investment in Health Catalyst, Inc. (NASDAQ:HCAT)May 25, 2025 | marketbeat.comPoint72 Asset Management L.P. Lowers Stake in Health Catalyst, Inc. (NASDAQ:HCAT)May 24, 2025 | marketbeat.com3 Stocks Under $10 with Questionable FundamentalsMay 20, 2025 | msn.comHealth Catalyst to Participate in Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by AnalystsMay 20, 2025 | marketbeat.comWhy Health Catalyst, Inc.’s (HCAT) Stock Is Down 5.02%May 16, 2025 | aaii.com1 Mooning Stock Worth Your Attention and 2 to AvoidMay 12, 2025 | finance.yahoo.comHEALTH CATALYST Earnings Results: $HCAT Reports Quarterly EarningsMay 9, 2025 | nasdaq.comHealth Catalyst, Inc.: Health Catalyst Reports First Quarter 2025 ResultsMay 9, 2025 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Rebuts Short Seller, Points to Strong Q1 & Global MomentumBy Jeffrey Neal Johnson | May 22, 2025View Archer Rebuts Short Seller, Points to Strong Q1 & Global MomentumAs Oil Prices Rebound, These Stocks Could Fuel the Next RallyBy Sarah Horvath | June 9, 2025View As Oil Prices Rebound, These Stocks Could Fuel the Next RallyAMD Accelerates Stack Development: Share Price to FollowBy Thomas Hughes | June 16, 2025View AMD Accelerates Stack Development: Share Price to FollowThese Are the Only 6 Stock Stocks in NVIDIA's 13F PortfolioBy Leo Miller | May 22, 2025View These Are the Only 6 Stock Stocks in NVIDIA's 13F PortfolioBuy the Dip? 3 Oil Stocks Poised for a Big ComebackBy Chris Markoch | May 22, 2025View Buy the Dip? 3 Oil Stocks Poised for a Big ComebackHCAT, EB, EVER, and CDLX Company DescriptionsCardlytics NASDAQ:CDLX$1.88 +0.37 (+24.50%) Closing price 04:00 PM EasternExtended Trading$1.92 +0.04 (+2.13%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Eventbrite NYSE:EB$2.46 +0.06 (+2.28%) Closing price 03:59 PM EasternExtended Trading$2.46 0.00 (0.00%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Eventbrite, Inc. operates a two-sided marketplace that provides self-service ticketing and marketing tools for event creators in the United States and internationally. Its platform integrates components needed to plan, promote, and produce live events that allow creators to reduce friction and costs, enhance reach, and drive ticket sales. The company was formerly known as Mollyguard Corporation and changed its name to Eventbrite, Inc. in 2009. Eventbrite, Inc. was incorporated in 2008 and is headquartered in San Francisco, California.EverQuote NASDAQ:EVER$24.34 -0.32 (-1.30%) Closing price 04:00 PM EasternExtended Trading$24.53 +0.19 (+0.78%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.Health Catalyst NASDAQ:HCAT$3.88 +0.08 (+2.11%) Closing price 04:00 PM EasternExtended Trading$3.67 -0.21 (-5.39%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
